Back
ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

Session: Latest Science in CV Prevention
Topic: Diabetes and the Heart
Speaker: Professor D. Bhatt (New York, US)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)
38 presentations
7 followers

6 more presentations in this session

Nationwide trends in stroke and atrial fibrillation in patients with incident type 2 diabetes

Speaker: Doctor C. Gyldenkerne (Aarhus, DK)

Access
Slides
Video
Thumbnail

CRISP-CT: Incorporating FAI-Score In Clinical Decision Making

Speaker: Professor C. Antoniades (Oxford, GB)

Access
Slides
Video
Thumbnail

Opiates and its effects on cardiovascular outcomes

Speaker: Doctor S. Liew (Melbourne, AU)

Access
Slides
Video
Thumbnail

E3 Trial: The 52-Week Results

Speaker: Doctor K. Filion (Montreal, CA)

Access
Slides
Video
Thumbnail

Long term effects of the Randomized Evaluation of Secondary Prevention by Outpatient Nurse Specialists-2 trial (RESPONSE-2)

Speaker: Doctor H. Jorstad (Amsterdam, NL)

Access
Slides
Video
Thumbnail

Access the full session

Latest Science in CV Prevention

Speakers: Professor D. Bhatt, Doctor C. Gyldenkerne, Professor C. Antoniades, Doctor S. Liew, Doctor K. Filion...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb